STERIS plc Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
STERIS plc (STE) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of -$2.30 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-07
- STERIS plc effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2026-06-30 was -$2.30M, a 123.96% decline year-over-year.
- STERIS plc effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2025-06-30 was $9.60M.
- STERIS plc effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-06-30 was -$1.30M.
- STERIS plc effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2023-06-30 was -$639.00K.
- STERIS plc effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2026 was $7.20M, a 3500.00% increase from fiscal 2025.
- STERIS plc effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2025 was $200.00K.
- STERIS plc effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2024 was -$2.10M.
- STERIS plc effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2023 was -$14.86M.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month as first filed | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month as first filed | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month as first filed | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.30M 10-Q · filed 2026-08-07 | |||||||
| 2026-03-31 | $7.20M 10-K · filed 2026-05-29 | |||||||
| 2025-12-31 | $11.60M 10-Q · filed 2026-02-06 | |||||||
| 2025-09-30 | $8.70M 10-Q · filed 2025-11-06 | |||||||
| 2025-06-30 | $9.60M 10-Q · filed 2026-08-07 | |||||||
| 2025-03-31 | $200.00K 10-K · filed 2026-05-29 | $185.00K 10-K · filed 2025-05-29 | ||||||
| 2024-12-31 | -$3.40M 10-Q · filed 2026-02-06 | -$3.43M 10-Q · filed 2025-02-07 | ||||||
| 2024-09-30 | $8.10M 10-Q · filed 2025-11-06 | $8.13M 10-Q · filed 2024-11-07 | ||||||
| 2024-06-30 | -$1.30M 10-Q · filed 2025-08-07 | -$1.33M 10-Q · filed 2024-08-08 | ||||||
| 2024-03-31 | -$2.10M 10-K · filed 2026-05-29 | -$2.06M 10-K · filed 2024-05-29 | ||||||
| 2023-12-31 | $1.93M 10-Q · filed 2025-02-07 | |||||||
| 2023-09-30 | -$5.57M 10-Q · filed 2024-11-07 | |||||||
| 2023-06-30 | -$639.00K 10-Q · filed 2024-08-08 | |||||||
| 2023-03-31 | -$14.86M 10-K · filed 2025-05-29 | |||||||
| 2022-12-31 | -$17.57M 10-Q · filed 2024-02-08 | |||||||
| 2022-09-30 | -$31.93M 10-Q · filed 2023-11-07 | |||||||
| 2022-06-30 | -$12.91M 10-Q · filed 2023-08-08 | |||||||
| 2022-03-31 | -$6.29M 10-K · filed 2024-05-29 | |||||||
| 2021-12-31 | -$4.83M 10-Q · filed 2023-02-08 | |||||||
| 2021-09-30 | -$5.17M 10-Q · filed 2022-11-09 | |||||||
| 2021-06-30 | $1.54M 10-Q · filed 2022-08-08 | |||||||
| 2021-03-31 | $19.85M 10-K · filed 2023-05-26 | |||||||
| 2020-03-31 | -$8.73M 10-K · filed 2022-05-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |